ITCMDBv1
Clinical TrialID 4886

Comparative Acute Effects of LSD, Psilocybin and Mescaline

NCT04227756

Healthy

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
4886
Evidence Id
4886
Core Evidence Id
4886
Source Clinical Trial Id
4863
Herb2 Clinical Trial Id
HBCT004863
Nct Id
NCT04227756
Title
Comparative Acute Effects of LSD, Psilocybin and Mescaline
Status
Completed
Phase
Phase 1
Study Result
No
Study Condition
Healthy
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Intervention
DRUG: LSD|DRUG: Psilocybin|DRUG: Mescaline|OTHER: Placebo
Intervention Allocation
Randomized
Intervention Model
Crossover
Intervention Mask
Quadruple
Intervention Purpose
Basic_Science
Gender
All
Age
Adult, Older_Adult
Enrollment
32
Outcome Measure
5 Dimensions of Altered States of Consciousness (5D-ASC), 5D-ASC subscale ratios, 18 months|fMRI resting state functional connectivity (RSFC), Spontaneous low-frequency fluctuations in BOLD signal during resting state, 18 months
Sponsor Collaborator
University Hospital, Basel, Switzerland
Funded By
OTHER
Location
University Hospital Basel, Clinical Trial Unit, Basel, BS, 4031, Switzerland
Other Id
BASEC 2019-02023
Start Date
2020-05-19
Primary Completion Date
2022-09-02
Completion Date
2022-09-02
First Posted
2020-01-14
Results First Posted
Last Update Posted
2024-01-24
Study Document
Study Url
https://clinicaltrials.gov/study/NCT04227756
Title Cn
Title En
Comparative Acute Effects of LSD, Psilocybin and Mescaline
Bilingual Status
semi_complete